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A total of 20 consecutive patients that
presented between 2003 and 2006 with herpes zoster
ophthalmicus were examined retrospectively as to their
Human Immune deficiency virus (HIV) status. Their
presentation, clinical findings and clinical course are also
analyzed.
: Of the 20 patients examined, there was a male
preponderance of 4:3 with most patients above 40 years
(35.4% between 41-50 years) and half of them were
married. Out of the twelve (n=12, 60%) patients whose
serum was tested for human immunodeficiency virus,
eight (n=8, 40%) were negative, while four (n=4, 20%)
were positive for the virus .Eight were not tested.
Using 40 years of age as the cutoff, those above 40 years
(12 in number), two (n=2, 25%) were seropositive while 9
were negative (75%). For those below 40 years (8 in
number), two (n=2, 25%) were positive while six were
negative (75%).
Upon treatment with antivirals (Zovirax ) in the majority of
cases there was complete resolution in 8 (57%) of the
patients with most of the sequelae occurring in those of
them who are seropositive.
: Correlation of impaired immune status with
Herpes zoster affectation was found to be more obvious in
the younger than 40 years group. Treatment with antivirals
gave good resolution in most cases. Blinding
complications were found more in those who were
seropositive.
: herpes zoster, HIV infection, Nigeria.
Herpes zoster is a painful vesiculobullous
dermatitis which occurs as a result of previously
established varicella zoster virus infection. It is a well
established fact that Herpes zoster ophthalmicus is a well
known marker of human immune deficiency virus infection
even in Africans. The aim of this study is to determine if
indeed the herpes zoster condition is a marker for the
immune deficiency condition called AIDS in our locality
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Introduction
Methodology
The Joint Uni ted Nat ions Programme on
HIV/AIDS(UNAIDS), reports that at the end of 2005 an
estimated 38.6million people worldwide were living with
Human immuno deficiency virus (HIV). Sub-Saharan
Africa was found to be the region with the largest burden
of the AIDS epidemic, while Nigeria had the largest
epidemic of HIV in West and Central Africa (1.2 – 4.2
million people).
Among individuals with HIV, approximately 70 -80% will
be treated for an HIV associated eye disorder during the
course of the illness. In many patients, opportunistic
disease may be the first manifestation of HIV infection.
Herpes zoster has been observed in 10 -20% of patients
infected with HIV.
Herpes zoster is a painful vesiculobullous dermatitis
which occurs as a result of previously established
varicella zoster virus infection. Herpes zoster can
involve any dermatome, when the ophthalmic division of
the trigeminal nerve is affected it is called herpes zoster
ophthalmicus. Herpes zoster may be the presenting
sign in HIV and may predict an increased risk for
developingAIDS in those already infected with HIV.
Patients with herpes zoster ophthalmicus who are seen
in the University of Port Harcourt Teaching Hospital
outpatient department are referred to the eye clinic to
manage their eye signs. It is a well established fact that
Herpes zoster ophthalmicus is a well known marker of
human immune deficiency virus infection even in
Africans. This was also the conclusion of a study carried
out in eastern Nigeria 10 years ago. However this has
not to the best of our knowledge been established in our
locality.
This study was carried out to find out if the same
situation prevails in our locality.
Folders of patients diagnosed to have herpes zoster
ophthalmicus between the year 2003 and 2006 were
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department of the University of Port Harcourt Teaching
Hospital, Port Harcourt, Rivers state and reviewed.
Vital statistics as well as details about complaints, ocular
findings, and investigations carried out, management
strategies and visual outcome were extracted from the
folders of the patients.
The data was analyzed manually.
Of the 20 patients, there were 13 males and 7 females
giving a male female ratio of 4:3.
The age range was between 18 and 79 years with the
majority falling between the 41-50 age groups (35.7%).
about 12 patients were over 40 years old.
Half of the patients came from Rivers state (50%) while
one of the patients was a Caucasian. Only one of the
patients was a Muslim. Others were Christians. There
was no predilection for a particular occupation with most
patients being civil servants, students, or traders. One of
them was a fisherman. Majority were married to one wife
(50%), 7 were single (35.7%) while there were 2 widows
involved. Most of the patients denied having multiple
partners (71.4%) while one person admitted that he had.
The presenting complaints were mainly rashes (70%),
followed by loss of vision (25%) and then tearing and eye
discomfort in order of frequency. The side of the face
most commonly affected is the left side (70%) as against
the right. Involvement of the tip of the nose was seen in 9
cases (45%), though it was not documented in 2 cases.
The pupil was sluggish but reactive in 2 cases, fixed in 7
cases while it was still active in 9 cases. In 2 cases it was
not documented. Most patients had been complaining for
a minimum of 4 days and a maximum of 20 weeks before
presentation.
Out of the twelve (n=12, 60%) patients whose serum was
tested for human immunodeficiency virus, eight (n=8,
40%) were negative, while four (n=4, 20%) were positive
for the virus .Eight were not tested.
Using 40 years of age as the cutoff, those above 40 years
(12 in number), two (n=2, 25%) were seropositive while 9
were negative (75%). For those below 40 years (8 in
number), two (n=2, 25%) were positive while six were
negative (75%).
The standard treatment given that provided relief was
topical Zovirax and topical steroids with majority of
patients receiving relief on an average of 2 visits. Most
patients (n=17, 85%) had no significant past ocular
history and in eleven (n=11) patients there was no
sequelae, with complete resolution.
Results
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Two (2) patients lost their vision completely while 2
patients developed a secondary cataract and 3
developed corneal opacities. Of these 7 patients with
significant sequelae, all presented as late as 3 to 12
weeks after symptoms had developed and 4 of the
patients were seropositive.
HIV infection causes a reduction in cellular immunity.
This predisposes patients to opportunistic infections.
Generally CD4+ T- lymphocyte count has been used to
predict the onset of certain ocular infections in patients
who are HIV positive but even if the patient has higher
Cd4 counts, problems could still occur. Ocular
complications occur in 75% of AIDS patients. .
Ophthalmic zoster, which is one of these complications
has an incidence of 3.2/1000 patients /year. Recent
reports from eastern Nigeria shows that herpes zoster
ophthalmicus accounts for 48% of the 50% of cases of
herpetic eye disease.
Herpes zoster ophthalmicus is a recrudescence of a
latent varicella zoster virus in the dorsal root ganglion of
the trigeminal nerve. The loss of regulatory control of T-
cells that occurs with aging and immunocompromised
conditions such as HIV infection and AIDS are believed
to contribute to the reactivation of the virus and the
morbidity that results there from. Herpes zoster
ophthalmicus accounts for 10 -25 % of all cases of
Herpes zos te r (Sh ing les ) . Herpes zos te r
infection(Shingles) is observed in 10 -20% of patients
with HIV infection and has been shown to indicate a
modest decline in immune function and also the first
clinical indication of immunodeficiency. Herpes zoster
ophthalmicus on its own may be the presenting sign in
HIV and may predict an increased risk for developing
AIDS in those already infected with HIV.
Patients with herpes zoster ophthalmicus usually
present with various stages of cutaneous lesions along
the distribution of the ophthalmic division of the
trigeminal nerve. The rashes typically start as macules
then progress to form papules, vesicles pustules and
eventually become crusted. Rashes are usually
preceded by a prodromal period with fever malaise and
headaches. Involvement of the nasociliary nerve as
evidenced by a rash on the tip of the nose, heralds
ocular involvement. Patients may therefore present to
the eye clinic with deterioration of vision, eye
discomfort, pain, tearing and redness .Ocular
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ophthalmicus include, blepharitis, conjunctivitis, keratitis,
uveitis and their sequelae.
In our study 70% of the patients presented with various
stages of development of the cutaneous rashes along the
distribution of the trigeminal nerve on the affected side of
the face. Twenty–five percent presented with visual loss
and others with tearing and eye discomfort. There was
involvement of the tip of the nose (Hutchinson’s sign) in
45% of the cases. A similar picture was reported in
southwestern Nigeria where 66.7% of patients with HIV,
presented with vesicular rashes. Herpes zoster
ophthalmicus ordinarily affects the middle aged and
elderly however since the HIV/AIDS pandemic it is
increasingly been observed in young adults and has been
associated in this age group with HIV seropositivity or
AIDS. However in our study majority of the patients were
between 40 and 51 years of age. Using 40 years as a
cutoff point, those above 40years demonstrated less
seropositivity (6 negative, 2 positive) than those below 40
years (1 negative, 2 positive).
The course of the disease (herpes zoster ophthalmicus) is
more severe and prolonged in patients with HIV/AIDS.
Complications maybe associated with inflammatory
changes (keratit is, episclerit is/sclerit is,orbital
12
6,13
v a s c u l i t i s ) . O t h e r s o c c u r f r o m n e r v e
damage,neurotrophic keratitis, ocular motor palsies
and neuralgia. This could lead to devastating
sequelae such as chronic ocular inflammation,
debilitating pain and the ultimate being loss of vision.
With regards to this study, most of the patients (57%)
responded to treatment with systemic and topical
acyclovir with complete recovery. Sequelae was seen
in 7 of our patients. Three had corneal opacities, 2 had
secondary cataracts and 2 lost their vision. Out of the 7
patients with significant sequelae, 4 of them were
seropositive.
Correlation of impaired immune status with Herpes
zoster affectation was found to be more obvious in the
younger than 40 years group. Treatment with antivirals
gave good resolution in most cases. It is recommended
that all patients presenting with herpes zoster should
have a serum test to rule out HIV carried out on them.
Also all patients, particularly those who have HIV with
suspected herpes zoster should be encouraged to
present early at the eye clinic so as to minimize blinding
complications.
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